Psychedelics pioneer keeps his inner hippy in check

Psychedelics pioneer keeps his inner hippy in check   After giving people LSD and psilocybin, Robin Carhart-Harris is convinced of psychedelic therapy’s potential – but he daren’t get too excited about it .entry-header “I have conviction in psychedelics as tools to fundamentally understand the mind and the brain” Liz Hingley ONE of the last times …

Read morePsychedelics pioneer keeps his inner hippy in check

Psychedelic medicine: the potential, the people, the politics

Trippy treatment James Worrell/Getty By Sean O’Neill It was quite a comedown in the 1970s when research into psychedelic medicine was virtually shut down in the West. Many countries were beginning to classify psychedelics as “schedule 1”, making them illegal, on the grounds that they were drugs of “abuse” with no agreed-upon medical use. The …

Read morePsychedelic medicine: the potential, the people, the politics

David Nutt – The Psychedelic Crusader

  David Nutt The Psychedelic Crusader In a society where almost all drugs have negative associations, it’s hard to have an open and rational discussion about their potential miraculous effects. /.post__head 52 Insights David Nutt The Psychedelic Crusader • 12th/Jan/2017 For almost 50 years LSD was banned worldwide and under no circumstances was any scientific …

Read moreDavid Nutt – The Psychedelic Crusader

Magic Mushrooms Could Be the Future of Antidepressants

We spoke to Dr. Mark Bolstridge, a clinical psychiatrist searching for alternative and unusual treatments for depression.

Bolstridge, alongside David Nutt, president of the British Neuroscience Association and former government drugs advisor, initially applied to run a psilocybin trial in 2013. Nutt had previously conducted small experiments before more stringent regulations around psychoactive substances were put into place. He felt that psilocybin had the potential to alleviate symptoms of depression and wanted to carry out further experiments.

Bolstridge is already in the process of searching for alternative and unusual treatments. In particular, he’s been looking into the hallucinogenic compound found within magic mushrooms: psilocybin.

“There are a distinct proportion of patients who don’t get better despite taking lots of different antidepressants,” says Dr. Mark Bolstridge, an honorary research associate at UCL and a clinical psychiatrist. “That’s frustrating as a clinician, that even though we do have a lot of drugs at our disposal, for some people, none of them work.”

found that some drug companies were selectively publishing studies on antidepressants that showed the drugs had a benefit and shelving others that showed there was no overall effect.

, doctors treat the causes in a crude way, with drugs “aimed at the wrong target,” often focusing on reducing stress rather than depression itself. Others have suggested that

The science of antidepressants, is not, as it goes, an exact science. Two patients can react differently to the same drug. For some people, many of the existing drugs won’t have any effect at all.